Sarin Vandana, Gaffin Robert D, Meininger Gerald A, Muthuchamy Mariappan
Department of Medical Physiology, Cardiovascular Research Institute, 336 Reynolds Medical Building, Texas A & M University System Health Science Center, College of Medicine, College Station, TX 77843-1114, USA.
J Physiol. 2005 Apr 15;564(Pt 2):603-17. doi: 10.1113/jphysiol.2005.083238. Epub 2005 Feb 17.
Integrins are considered to be an important mechanosensor in cardiac myocytes. To test whether integrins can influence cardiac contractile function, the force-frequency relationships of mouse papillary muscle bundles were measured in the presence or absence of a synthetic integrin-binding peptide, GRGDNP (gly-arg-gly-asp-asn-pro). Results demonstrate that in the presence of an arginine-glycine-aspartic acid (RGD)-containing synthetic peptide, contractile force was depressed significantly by, 28% at 4 Hz, 37.7% at 5 Hz and 20% at 10 Hz (n = 6, P < 0.01). Treatment of myofibres with either protease-generated fragments of denatured collagen (Type I) or denatured collagen that contain the RGD motif, also reduced force production significantly. An integrin-activating antibody for beta(1) integrin inhibited the force similar to synthetic RGD peptide. Function-blocking integrin antibodies for alpha(5) and beta(1) integrins reversed the effect of the RGD-containing peptide, and alpha(5) integrin also reversed the effect of proteolytic fragments of denatured collagen on contractile force, whereas experiments with function-blocking antibody for beta(3) integrin did not reverse the effect of RGD peptide. Force-Ca(2)(+) measurements showed that the depressed rate of force generation observed in the presence of the RGD-containing peptide was associated with reduced Ca(2)(+). Data analyses further demonstrated that force per unit of Ca(2)(+) was reduced, suggesting that the myofilament activation process was altered. In addition, inhibition of PKC enzyme using the selective, cell-permeable inhibitor Ro-32-0432, reversed the activity of RGD peptide on papillary muscle bundles. In conclusion, these data indicate that RGD peptide, acting via alpha(5)beta(1) integrin, depresses the force production from papillary muscle bundles, partly associated with changes in Ca(2)(+) and the myofilament activation processes, that is modulated by PKCepsilon.
整合素被认为是心肌细胞中一种重要的机械传感器。为了测试整合素是否能影响心脏收缩功能,在存在或不存在合成整合素结合肽GRGDNP(甘氨酸-精氨酸-甘氨酸-天冬氨酸-天冬酰胺-脯氨酸)的情况下,测量了小鼠乳头肌束的力-频率关系。结果表明,在存在含精氨酸-甘氨酸-天冬氨酸(RGD)的合成肽时,收缩力在4Hz时显著降低28%,在5Hz时降低37.7%,在10Hz时降低20%(n = 6,P < 0.01)。用蛋白酶产生的变性I型胶原蛋白片段或含有RGD基序的变性胶原蛋白处理肌纤维,也显著降低了力的产生。一种针对β1整合素的整合素激活抗体抑制力的作用类似于合成RGD肽。针对α5和β1整合素的功能阻断整合素抗体逆转了含RGD肽的作用,α5整合素也逆转了变性胶原蛋白蛋白水解片段对收缩力的作用,而针对β3整合素的功能阻断抗体实验并未逆转RGD肽的作用。力-[Ca2+]i测量表明,在存在含RGD肽的情况下观察到的力产生速率降低与[Ca2+]i降低有关。数据分析进一步表明,每单位Ca2+的力降低,表明肌丝激活过程发生了改变。此外,使用选择性、细胞可渗透抑制剂Ro-32-0432抑制PKC酶,逆转了RGD肽对乳头肌束的活性。总之,这些数据表明,RGD肽通过α5β1整合素起作用,降低乳头肌束的力产生,部分与[Ca2+]i和肌丝激活过程的变化有关,而这一过程受PKCε调节。